Jiangxi Institute of Biological Products Inc. (HKG:6915)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.43
+1.10 (20.64%)
Last updated: Jul 17, 2026, 10:16 AM HKT

HKG:6915 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
235.41220.76198.02
Revenue Growth (YoY)
6.64%11.48%-
Cost of Revenue
54.7265.6263.72
Gross Profit
180.69155.14134.31
Selling, General & Admin
53.4559.2162.19
Research & Development
23.713.6824.23
Operating Expenses
79.472.6486.26
Operating Income
101.2882.548.04
Interest Expense
-0.03-2.23-0.67
Interest & Investment Income
0.170.310.28
Other Non Operating Income (Expenses)
-14.43-0.642.11
EBT Excluding Unusual Items
86.9979.9549.76
Gain (Loss) on Sale of Investments
0.130.110.26
Gain (Loss) on Sale of Assets
3.76-0.030.06
Asset Writedown
18.3811.6313.5
Other Unusual Items
-0.11-
Pretax Income
109.2691.7763.59
Income Tax Expense
14.4716.638.11
Earnings From Continuing Operations
94.7975.1455.48
Minority Interest in Earnings
--0.01
Net Income
94.7975.1455.49
Net Income to Common
94.7975.1455.49
Net Income Growth
26.16%35.40%-
Shares Outstanding (Basic)
272272272
Shares Outstanding (Diluted)
272272272
EPS (Basic)
0.350.280.20
EPS (Diluted)
0.350.280.20
EPS Growth
26.16%35.40%-
Free Cash Flow
20.7987.4138.19
Free Cash Flow Per Share
0.080.320.14
Dividend Per Share
--0.150
Gross Margin
76.75%70.28%67.82%
Operating Margin
43.03%37.37%24.26%
Profit Margin
40.27%34.04%28.02%
Free Cash Flow Margin
8.83%39.60%19.28%
EBITDA
112.2793.3859.01
EBITDA Margin
47.69%42.30%29.80%
D&A For EBITDA
10.9910.8810.97
EBIT
101.2882.548.04
EBIT Margin
43.03%37.37%24.26%
Effective Tax Rate
13.24%18.12%12.76%